TrialAIDS research and human retroviruses2019

Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210.

Victoria A Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.